BMY logo

Bristol-Myers Squibb Company (BMY) Net income

annual net income:

-$8.93B-$16.97B(-211.11%)
December 31, 2024

Summary

  • As of today (August 26, 2025), BMY annual net profit is -$8.93 billion, with the most recent change of -$16.97 billion (-211.11%) on December 31, 2024.
  • During the last 3 years, BMY annual net income has fallen by -$15.95 billion (-227.36%).
  • BMY annual net income is now -211.11% below its all-time high of $8.04 billion, reached on December 31, 2023.

Performance

BMY Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

quarterly net income:

$1.31B-$1.15B(-46.67%)
June 30, 2025

Summary

  • As of today (August 26, 2025), BMY quarterly net profit is $1.31 billion, with the most recent change of -$1.15 billion (-46.67%) on June 30, 2025.
  • Over the past year, BMY quarterly net income has dropped by -$371.00 million (-22.03%).
  • BMY quarterly net income is now -46.67% below its all-time high of $2.46 billion, reached on March 31, 2025.

Performance

BMY quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM net income:

$5.07B-$371.00M(-6.82%)
June 30, 2025

Summary

  • As of today (August 26, 2025), BMY TTM net profit is $5.07 billion, with the most recent change of -$371.00 million (-6.82%) on June 30, 2025.
  • Over the past year, BMY TTM net income has increased by +$11.59 billion (+177.60%).
  • BMY TTM net income is now -38.99% below its all-time high of $8.30 billion, reached on September 30, 2023.

Performance

BMY TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BMY Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-211.1%-22.0%+177.6%
3 y3 years-227.4%-8.1%-23.7%
5 y5 years-358.2%+1741.3%+1038.2%

BMY Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-211.1%at low-46.7%+111.0%-39.0%+156.7%
5 y5-year-211.1%+0.7%-46.7%+111.0%-39.0%+156.3%
alltimeall time-211.1%+0.7%-46.7%+111.0%-39.0%+156.3%

BMY Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.31B(-46.7%)
$5.07B(-6.8%)
Mar 2025
-
$2.46B(+3139.5%)
$5.44B(-160.9%)
Dec 2024
-$8.93B(-211.1%)
$76.00M(-93.7%)
-$8.93B(+23.3%)
Sep 2024
-
$1.22B(-27.9%)
-$7.25B(+11.0%)
Jun 2024
-
$1.68B(-114.1%)
-$6.53B(+6.4%)
Mar 2024
-
-$11.91B(-775.8%)
-$6.13B(-176.3%)
Dec 2023
$8.04B(+26.7%)
$1.76B(-8.9%)
$8.04B(-3.2%)
Sep 2023
-
$1.93B(-6.9%)
$8.30B(+4.1%)
Jun 2023
-
$2.08B(-8.4%)
$7.98B(+8.8%)
Mar 2023
-
$2.27B(+12.0%)
$7.33B(+15.5%)
Dec 2022
$6.34B(-9.5%)
$2.02B(+25.9%)
$6.34B(-5.2%)
Sep 2022
-
$1.61B(+12.5%)
$6.69B(+0.8%)
Jun 2022
-
$1.43B(+11.4%)
$6.64B(+5.9%)
Mar 2022
-
$1.28B(-45.9%)
$6.27B(-10.6%)
Dec 2021
$7.01B(-178.0%)
$2.37B(+52.8%)
$7.01B(-230.3%)
Sep 2021
-
$1.55B(+46.3%)
-$5.38B(+6.4%)
Jun 2021
-
$1.06B(-47.7%)
-$5.06B(-18.4%)
Mar 2021
-
$2.03B(-120.2%)
-$6.20B(-31.1%)
Dec 2020
-$8.99B(-360.0%)
-$10.03B(-633.9%)
-$8.99B(>+9900.0%)
Sep 2020
-
$1.88B(-2447.5%)
-$28.00M(-94.8%)
Jun 2020
-
-$80.00M(-89.6%)
-$540.00M(-155.2%)
Mar 2020
-
-$766.00M(-27.7%)
$979.00M(-71.7%)
Dec 2019
$3.46B(-30.1%)
-$1.06B(-177.6%)
$3.46B(-39.4%)
Sep 2019
-
$1.37B(-5.1%)
$5.71B(-8.7%)
Jun 2019
-
$1.44B(-16.1%)
$6.26B(+20.3%)
Mar 2019
-
$1.72B(+44.1%)
$5.20B(+4.4%)
Dec 2018
$4.95B(+407.4%)
$1.19B(-37.8%)
$4.98B(+241.0%)
Sep 2018
-
$1.91B(+400.5%)
$1.46B(+261.4%)
Jun 2018
-
$382.00M(-74.4%)
$404.00M(-57.2%)
Mar 2018
-
$1.50B(-164.2%)
$944.00M(-3.2%)
Dec 2017
$975.00M(-78.4%)
-$2.33B(-372.1%)
$975.00M(-76.8%)
Sep 2017
-
$856.00M(-7.2%)
$4.20B(-7.9%)
Jun 2017
-
$922.00M(-39.6%)
$4.56B(-5.5%)
Mar 2017
-
$1.53B(+69.9%)
$4.83B(+7.1%)
Dec 2016
$4.51B(+176.3%)
$898.00M(-26.1%)
$4.51B(+29.5%)
Sep 2016
-
$1.22B(+2.3%)
$3.48B(+16.2%)
Jun 2016
-
$1.19B(-1.5%)
$3.00B(+76.5%)
Mar 2016
-
$1.21B(-1034.9%)
$1.70B(+0.4%)
Dec 2015
$1.63B(-19.6%)
-$129.00M(-117.7%)
$1.69B(-8.5%)
Sep 2015
-
$730.00M(-763.6%)
$1.85B(-0.1%)
Jun 2015
-
-$110.00M(-109.2%)
$1.85B(-19.4%)
Mar 2015
-
$1.20B(+4340.7%)
$2.29B(+13.0%)
Dec 2014
$2.03B(-21.4%)
$27.00M(-96.3%)
$2.03B(-25.9%)
Sep 2014
-
$732.00M(+119.2%)
$2.74B(+1.5%)
Jun 2014
-
$334.00M(-64.3%)
$2.70B(-6.8%)
Mar 2014
-
$936.00M(+27.3%)
$2.89B(+12.1%)
Dec 2013
$2.58B(+3.2%)
$735.00M(+6.2%)
$2.58B(-6.8%)
Sep 2013
-
$692.00M(+30.6%)
$2.77B(+103.0%)
Jun 2013
-
$530.00M(-14.9%)
$1.36B(-16.9%)
Mar 2013
-
$623.00M(-32.6%)
$1.64B(-34.3%)
Dec 2012
$2.50B(-52.4%)
$924.00M(-229.6%)
$2.50B(-10.9%)
Sep 2012
-
-$713.00M(-188.2%)
$2.81B(-42.4%)
Jun 2012
-
$808.00M(-45.4%)
$4.87B(-9.3%)
Mar 2012
-
$1.48B(+20.5%)
$5.37B(+2.2%)
Dec 2011
$5.25B(+16.7%)
$1.23B(-9.2%)
$5.25B(+8.0%)
Sep 2011
-
$1.35B(+3.7%)
$4.86B(+1.1%)
Jun 2011
-
$1.30B(-4.4%)
$4.81B(+0.8%)
Mar 2011
-
$1.36B(+62.3%)
$4.77B(+5.9%)
Dec 2010
$4.50B(+2.2%)
$841.00M(-35.2%)
$4.50B(-1.4%)
Sep 2010
-
$1.30B(+2.6%)
$4.57B(+0.3%)
Jun 2010
-
$1.26B(+15.2%)
$4.55B(-0.6%)
Mar 2010
-
$1.10B(+21.1%)
$4.58B(+4.1%)
Dec 2009
$4.40B(+6.0%)
$907.00M(-29.4%)
$4.40B(-11.2%)
Sep 2009
-
$1.28B(-0.5%)
$4.96B(+9.7%)
Jun 2009
-
$1.29B(+40.6%)
$4.52B(+7.8%)
Mar 2009
-
$919.00M(-37.2%)
$4.19B(-0.3%)
Dec 2008
$4.15B(+52.0%)
$1.46B(+72.8%)
$4.21B(+57.4%)
Sep 2008
-
$847.00M(-12.0%)
$2.67B(-7.7%)
Jun 2008
-
$963.00M(+3.4%)
$2.89B(+2.2%)
Mar 2008
-
$931.00M(-1449.3%)
$2.83B(+3.7%)
Dec 2007
$2.73B(+46.7%)
-$69.00M(-106.5%)
$2.73B(+1.8%)
Sep 2007
-
$1.07B(+18.8%)
$2.68B(+31.7%)
Jun 2007
-
$900.00M(+8.3%)
$2.04B(+2.3%)
Mar 2007
-
$831.00M(-804.2%)
$1.99B(-1.7%)
Dec 2006
$1.86B(-48.0%)
-$118.00M(-127.8%)
$2.02B(-27.6%)
Sep 2006
-
$424.00M(-50.4%)
$2.80B(-19.9%)
Jun 2006
-
$854.00M(-1.3%)
$3.49B(-7.8%)
Mar 2006
-
$865.00M(+32.3%)
$3.79B(+5.7%)
Dec 2005
$3.58B
$654.00M(-41.6%)
$3.58B(+12.2%)
Sep 2005
-
$1.12B(-2.8%)
$3.19B(+7.0%)
DateAnnualQuarterlyTTM
Jun 2005
-
$1.15B(+74.4%)
$2.98B(+19.9%)
Mar 2005
-
$660.00M(+151.0%)
$2.49B(-14.2%)
Dec 2004
$2.90B(-16.5%)
$263.00M(-71.1%)
$2.90B(-9.1%)
Sep 2004
-
$910.00M(+38.9%)
$3.19B(-2.0%)
Jun 2004
-
$655.00M(-38.8%)
$3.25B(-7.4%)
Mar 2004
-
$1.07B(+93.3%)
$3.52B(+9.0%)
Dec 2003
$3.47B(+46.4%)
$554.00M(-43.2%)
$3.23B(+2.6%)
Sep 2003
-
$975.00M(+6.3%)
$3.15B(+24.0%)
Jun 2003
-
$917.00M(+17.4%)
$2.54B(+17.9%)
Mar 2003
-
$781.00M(+65.1%)
$2.15B(+7.0%)
Dec 2002
$2.37B(+10.5%)
$473.00M(+28.9%)
$2.01B(+310.6%)
Sep 2002
-
$367.00M(-30.9%)
$490.00M(-63.8%)
Jun 2002
-
$531.00M(-17.2%)
$1.35B(-29.7%)
Mar 2002
-
$641.00M(-161.1%)
$1.93B(-23.8%)
Dec 2001
$2.15B(-47.6%)
-$1.05B(-185.2%)
$2.53B(-45.6%)
Sep 2001
-
$1.23B(+11.7%)
$4.64B(+7.8%)
Jun 2001
-
$1.10B(-11.3%)
$4.31B(+0.3%)
Mar 2001
-
$1.24B(+16.3%)
$4.30B(+0.5%)
Dec 2000
$4.10B(-1.7%)
$1.07B(+19.7%)
$4.27B(+0.4%)
Sep 2000
-
$893.00M(-18.1%)
$4.26B(-4.6%)
Jun 2000
-
$1.09B(-10.6%)
$4.46B(+3.2%)
Mar 2000
-
$1.22B(+16.1%)
$4.32B(+3.7%)
Dec 1999
$4.17B(+32.7%)
$1.05B(-4.1%)
$4.17B(+18.1%)
Sep 1999
-
$1.10B(+15.2%)
$3.53B(+3.9%)
Jun 1999
-
$952.00M(-10.7%)
$3.40B(+3.6%)
Mar 1999
-
$1.07B(+158.1%)
$3.28B(+4.4%)
Dec 1998
$3.14B(-2.0%)
$413.00M(-57.2%)
$3.14B(-11.0%)
Sep 1998
-
$966.00M(+15.7%)
$3.53B(+3.2%)
Jun 1998
-
$835.00M(-9.9%)
$3.42B(+2.9%)
Mar 1998
-
$927.00M(+15.6%)
$3.32B(+3.7%)
Dec 1997
$3.21B(+12.5%)
$802.00M(-6.2%)
$3.21B(+2.8%)
Sep 1997
-
$855.00M(+15.9%)
$3.12B(+3.4%)
Jun 1997
-
$738.00M(-8.9%)
$3.02B(+2.8%)
Mar 1997
-
$810.00M(+13.1%)
$2.93B(+2.9%)
Dec 1996
$2.85B(+57.3%)
$716.00M(-4.9%)
$2.85B(+43.1%)
Sep 1996
-
$753.00M(+15.0%)
$1.99B(+3.3%)
Jun 1996
-
$655.00M(-9.8%)
$1.93B(+2.5%)
Mar 1996
-
$726.00M(-611.3%)
$1.88B(+3.8%)
Dec 1995
$1.81B(-1.6%)
-$142.00M(-120.6%)
$1.81B(-11.7%)
Sep 1995
-
$689.00M(+13.3%)
$2.05B(+3.4%)
Jun 1995
-
$608.00M(-7.5%)
$1.98B(+3.4%)
Mar 1995
-
$657.00M(+570.4%)
$1.92B(+4.1%)
Dec 1994
$1.84B(-6.0%)
$98.00M(-84.2%)
$1.84B(-7.9%)
Sep 1994
-
$621.00M(+14.6%)
$2.00B(+0.7%)
Jun 1994
-
$542.00M(-6.7%)
$1.99B(+1.1%)
Mar 1994
-
$581.00M(+127.0%)
$1.97B(+0.3%)
Dec 1993
$1.96B(+27.4%)
$256.00M(-57.9%)
$1.96B(-4.0%)
Sep 1993
-
$608.00M(+16.7%)
$2.04B(+0.9%)
Jun 1993
-
$521.00M(-9.4%)
$2.02B(+1.7%)
Mar 1993
-
$575.00M(+70.6%)
$1.99B(+1.4%)
Dec 1992
$1.54B(-25.2%)
$337.00M(-42.8%)
$1.96B(-8.1%)
Sep 1992
-
$589.00M(+20.7%)
$2.13B(+1.2%)
Jun 1992
-
$488.00M(-10.9%)
$2.11B(-0.1%)
Mar 1992
-
$548.00M(+7.5%)
$2.11B(+2.7%)
Dec 1991
$2.06B(+17.6%)
$510.00M(-9.4%)
$2.06B(+4.3%)
Sep 1991
-
$563.00M(+14.9%)
$1.97B(+3.5%)
Jun 1991
-
$490.00M(-0.6%)
$1.91B(+4.0%)
Mar 1991
-
$493.00M(+15.7%)
$1.83B(+4.8%)
Dec 1990
$1.75B(+134.0%)
$426.00M(-14.1%)
$1.75B(+80.4%)
Sep 1990
-
$496.00M(+18.9%)
$969.00M(+9.6%)
Jun 1990
-
$417.00M(+2.0%)
$884.00M(+8.9%)
Mar 1990
-
$409.00M(-215.9%)
$812.00M(+8.7%)
Dec 1989
$747.00M(-9.9%)
-$353.00M(-185.9%)
$747.00M(-46.4%)
Sep 1989
-
$411.00M(+19.1%)
$1.39B(+4.2%)
Jun 1989
-
$345.00M(+0.3%)
$1.34B(+3.1%)
Mar 1989
-
$344.00M(+17.4%)
$1.30B(+3.4%)
Dec 1988
$829.00M(+16.8%)
$293.00M(-17.5%)
$1.25B(+2.1%)
Sep 1988
-
$355.00M(+16.4%)
$1.23B(+7.7%)
Jun 1988
-
$305.00M(+1.3%)
$1.14B(+3.4%)
Mar 1988
-
$301.00M(+12.7%)
$1.10B(+3.2%)
Dec 1987
$709.60M(+20.4%)
$267.00M(0.0%)
$1.07B(+33.3%)
Sep 1987
-
$267.00M(0.0%)
$801.00M(+50.0%)
Jun 1987
-
$267.00M(0.0%)
$534.00M(+100.0%)
Mar 1987
-
$267.00M
$267.00M
Dec 1986
$589.50M(+10.9%)
-
-
Dec 1985
$531.40M(+12.5%)
-
-
Dec 1984
$472.40M(+15.8%)
-
-
Dec 1983
$408.00M(+17.0%)
-
-
Dec 1982
$348.70M(+14.0%)
-
-
Dec 1981
$305.80M(+13.0%)
-
-
Dec 1980
$270.60M
-
-

FAQ

  • What is Bristol-Myers Squibb Company annual net profit?
  • What is the all time high annual net income for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company annual net income year-on-year change?
  • What is Bristol-Myers Squibb Company quarterly net profit?
  • What is the all time high quarterly net income for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company quarterly net income year-on-year change?
  • What is Bristol-Myers Squibb Company TTM net profit?
  • What is the all time high TTM net income for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company TTM net income year-on-year change?

What is Bristol-Myers Squibb Company annual net profit?

The current annual net income of BMY is -$8.93B

What is the all time high annual net income for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high annual net profit is $8.04B

What is Bristol-Myers Squibb Company annual net income year-on-year change?

Over the past year, BMY annual net profit has changed by -$16.97B (-211.11%)

What is Bristol-Myers Squibb Company quarterly net profit?

The current quarterly net income of BMY is $1.31B

What is the all time high quarterly net income for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high quarterly net profit is $2.46B

What is Bristol-Myers Squibb Company quarterly net income year-on-year change?

Over the past year, BMY quarterly net profit has changed by -$371.00M (-22.03%)

What is Bristol-Myers Squibb Company TTM net profit?

The current TTM net income of BMY is $5.07B

What is the all time high TTM net income for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high TTM net profit is $8.30B

What is Bristol-Myers Squibb Company TTM net income year-on-year change?

Over the past year, BMY TTM net profit has changed by +$11.59B (+177.60%)
On this page